JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 21 June 2006. doi:10.1136/jcp.2005.034389
Journal of Clinical Pathology 2007;60:1-7
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jcp.2005.034389v1
60/1/1    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santos, G. C
Right arrow Articles by Squire, J A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santos, G. C
Right arrow Articles by Squire, J A
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cancer
Topic Collections
Right arrow Editor's choice

REVIEW

Chromosome 6p amplification and cancer progression

Gda C Santos1,2,3, M Zielenska4,5, M Prasad1, J A Squire1,4,6

1 Department of Applied Molecular Oncology, Ontario Cancer Institute, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada
2 Department of Pathology, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
3 CIHR Molecular Oncologic Pathology Program, Toronto, Ontario, Canada
4 Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
5 Department of Pathology and Laboratory Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada
6 Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada

Correspondence to:
J A Squire
Ontario Cancer Institute, Princess Margaret Hospital, Room 9-717, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9; jeremy.squire{at}utoronto.ca
ABSTRACT
Chromosomal imbalances represent an important mechanism in cancer progression. A clear association between DNA copy-number aberrations and prognosis has been found in a variety of tumours. Comparative genomic hybridisation studies have detected copy-number increases affecting chromosome 6p in several types of cancer. A systematic analysis of large tumour cohorts is required to identify genomic imbalances of 6p that correlate with a distinct clinical feature of disease progression. Recent findings suggest that a central part of the short arm of chromosome 6p harbours one or more oncogenes directly involved in tumour progression. Gains at 6p have been associated with advanced or metastatic disease, poor prognosis, venous invasion in bladder, colorectal, ovarian and hepatocellular carcinomas. Copy number gains of 6p DNA have been described in a series of patients who presented initially with follicle centre lymphoma, which subsequently transformed to diffuse large B cell lymphoma. Melanoma cytogenetics has consistently identified aberrations of chromosome 6, and a correlation with lower overall survival has been described. Most of the changes observed in tumours to date map to the 6p21–p23 region, which encompasses approximately half of the genes on all of chromosome 6 and one third of the number of CpG islands in this chromosome. Analyses of the genes that cluster to the commonly amplified regions of chromosome 6p have helped to identify a small number of molecular pathways that become deregulated during tumour progression in diverse tumour types. Such pathways offer promise for new treatments in the future.


Abbreviations: BCC, basal cell carcinoma; CGH, comparative genomic hybridisation; CRC, colorectal carcinoma; HCC, hepatocellular carcinoma




This article has been cited by other articles:


Home page
BloodHome page
L. P. Gondek, R. Tiu, C. L. O'Keefe, M. A. Sekeres, K. S. Theil, and J. P. Maciejewski
Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML
Blood, February 1, 2008; 111(3): 1534 - 1542.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.